• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Preliminary findings on clinical and immunological effects of subcutaneously administered interleukin-2 + alpha-interferon combination in the treatment of advanced renal carcinoma].

作者信息

Buda F, Buda C, Croatto T, Costa B, Aragona P, Tuveri G

机构信息

Servizio di Oncologia Medica, Ospedale S. Maria dei Battuti, USL 9 Sanvitese, San Vito al Tagliamento.

出版信息

Recenti Prog Med. 1995 Jul-Aug;86(7-8):304-5.

PMID:7569288
Abstract
摘要

相似文献

1
[Preliminary findings on clinical and immunological effects of subcutaneously administered interleukin-2 + alpha-interferon combination in the treatment of advanced renal carcinoma].[皮下注射白细胞介素-2与α-干扰素联合治疗晚期肾癌的临床及免疫学效果初步研究]
Recenti Prog Med. 1995 Jul-Aug;86(7-8):304-5.
2
Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.转移性肾细胞癌患者接受白细胞介素-2、α干扰素和视黄酸治疗的临床和免疫学参数的相关性
Anticancer Res. 1998 May-Jun;18(3B):1883-90.
3
Immunotherapy for metastatic renal cell carcinoma.转移性肾细胞癌的免疫疗法。
BJU Int. 2007 May;99(5 Pt B):1282-8. doi: 10.1111/j.1464-410X.2007.06818.x.
4
[Treatment of advanced renal cell carcinoma with subcutaneous administration of interleukin 2 and interferon-alpha].皮下注射白细胞介素-2和α干扰素治疗晚期肾细胞癌
Urologe A. 1994 Sep;33(5):434-9.
5
Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.白细胞介素-2（IL2）用于转移性肾细胞癌和黑色素瘤的两项连续II期研究结果：大剂量持续静脉输注IL2以及皮下注射IL2联合α干扰素。
Rev Med Univ Navarra. 1996 Jul-Sep;40(3):6-12.
6
[Immunotherapeutic treatment for metastatic renal carcinoma].
Actas Urol Esp. 1998 Jan;22(1):29-33.
7
[Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].
Urologe A. 1993 Jul;32(4):290-4.
8
Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design--the Subcutaneous Administration Propeukin Program Cooperative Group.皮下注射白细胞介素-2和干扰素α治疗转移性肾细胞癌患者：SCAPP III的最终结果，一项采用序贯分析设计的大型多中心II期非随机研究——皮下给药Propeukin项目合作组
J Clin Oncol. 2003 Nov 1;21(21):3987-94. doi: 10.1200/JCO.2003.02.073.
9
Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferon.采用白细胞介素-2、淋巴因子激活的杀伤细胞和α干扰素联合治疗播散性肾细胞癌。
Prog Clin Biol Res. 1992;378:225-33.
10
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.标准白细胞介素-2（IL-2）和干扰素-α免疫疗法与IL-2和表柔比星免疫化疗联合疗法治疗转移性肾细胞癌的比较
Anticancer Res. 1998 May-Jun;18(3B):2021-6.